In Computed Tomography (CT) imaging, the ring artifacts caused by the inconsistent detector response can significantly degrade the reconstructed images, having negative impacts on the subsequent applications. The new generation of CT systems based on photon-counting detectors are affected by ring artifacts more severely. The flexibility and variety of detector responses make it difficult to build a well-defined model to characterize the ring artifacts. In this context, this study proposes the global dependency-enhanced dual-domain parallel neural network for Ring Artifact Removal (RAR). First, based on the fact that the features of ring artifacts are different in Cartesian and Polar coordinates, the parallel architecture is adopted to construct the deep neural network so that it can extract and exploit the latent features from different domains to improve the performance of ring artifact removal. Besides, the ring artifacts are globally relevant whether in Cartesian or Polar coordinate systems, but convolutional neural networks show inherent shortcomings in modeling long-range dependency. To tackle this problem, this study introduces the novel Mamba mechanism to achieve a global receptive field without incurring high computational complexity. It enables effective capture of the long-range dependency, thereby enhancing the model performance in image restoration and artifact reduction. The experiments on the simulated data validate the effectiveness of the dual-domain parallel neural network and the Mamba mechanism, and the results on two unseen real datasets demonstrate the promising performance of the proposed RAR algorithm in eliminating ring artifacts and recovering image details.

Cardiac CT plays an important role in diagnosing heart diseases but is conventionally limited by its complex workflow that requires dedicated phase and bolus tracking devices [e.g., electrocardiogram (ECG) gating]. This work reports first progress towards robust and autonomous cardiac CT exams through joint deep learning (DL) and analytical analysis of pulsed-mode projections (PMPs). To this end, cardiac phase and its uncertainty were simultaneously estimated using a novel projection domain cardiac phase estimation network (PhaseNet), which utilizes sliding-window multi-channel feature extraction strategy and a long short-term memory (LSTM) block to extract temporal correlation between time-distributed PMPs. An uncertainty-driven Viterbi (UDV) regularizer was developed to refine the DL estimations at each time point through dynamic programming. Stronger regularization was performed at time points where DL estimations have higher uncertainty. The performance of the proposed phase estimation pipeline was evaluated using accurate physics-based emulated data. PhaseNet achieved improved phase estimation accuracy compared to the competing methods in terms of RMSE (~50% improvement vs. standard CNN-LSTM; ~24% improvement vs. multi-channel residual network). The added UDV regularizer resulted in an additional ~14% improvement in RMSE, achieving accurate phase estimation with <6% RMSE in cardiac phase (phase ranges from 0-100%). To our knowledge, this is the first publication of prospective cardiac phase estimation in the projection domain. Combined with our previous work on PMP-based bolus curve estimation, the proposed method could potentially be used to achieve autonomous cardiac scanning without ECG device and expert-in-the-loop bolus timing.

To explore the association between pretherapeutic contrast-enhanced cone beam breast CT (CE-CBBCT) features and pathological complete response (pCR), and to develop a predictive model that integrates clinicopathological and imaging features. In this prospective study, a cohort of 200 female patients who underwent CE-CBBCT prior to neoadjuvant therapy and surgery was divided into train (n=150) and test (n=50) sets in a 3:1 ratio. Optimal predictive features were identified using univariate logistic regression and recursive feature elimination with cross-validation (RFECV). Models were constructed using XGBoost and evaluated through the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis. The performance of combined model was further evaluated across molecular subtypes. Feature significance within the combined model was determined using the SHapley Additive exPlanation (SHAP) algorithm. The model incorporating three clinicopathological and six CE-CBBCT imaging features demonstrated robust predictive performance for pCR, with area under curves (AUCs) of 0.924 in the train set and 0.870 in the test set. Molecular subtype, spiculation, and adjacent vascular sign (AVS) grade emerged as the most influential SHAP features. The highest AUCs were observed for HER2-positive subgroup (train: 0.935; test: 0.844), followed by luminal (train: 0.841; test: 0.717) and triple-negative breast cancer (TNBC; train: 0.760; test: 0.583). SHAP analysis indicated that spiculation was crucial for luminal breast cancer prediction, while AVS grade was critical for HER2-positive and TNBC cases. Integrating clinicopathological and CE-CBBCT imaging features enhanced pCR prediction accuracy, particularly in HER2-positive cases, underscoring its potential clinical applicability.

Overuse of radiography studies and underuse of conservative therapies for cranial deformities in neonates is a known inefficiency in pediatric craniofacial healthcare. This study sought to establish whether the introduction of artificial intelligence (AI)-generated craniometrics and craniometric interpretations into craniofacial clinical workflow improved resource utilization patterns in the initial evaluation and management of neonatal cranial deformities. A retrospective chart review of pediatric patients referred for head shape concerns between January 2019 and June 2023 was conducted. Patient demographics, final encounter diagnosis, review of an AI analysis, and provider orders were documented. Patients were divided based on whether an AI cranial deformity analysis was documented as reviewed during the index evaluation, then both groups were propensity matched. Rates of index-encounter radiology studies, physical therapy (PT), orthotic therapy, and craniofacial specialist follow-up evaluations were compared using logistic regression and ANOVA analyses. One thousand patient charts were reviewed (663 conventional encounters, 337 AI-assisted encounters). One-to-one propensity matching was performed between these groups. AI models were significantly more likely to be reviewed during telemedicine encounters and advanced practice provider (APP) visits (54.8% telemedicine vs 11.4% in-person, p < 0.0001; 12.3% physician vs 44.4% APP, p < 0.0001). All AI diagnoses of craniosynostosis versus benign deformities were congruent with final diagnoses. AI model review was associated with a significant increase in the use of orthotic therapies for neonatal cranial deformities (31.5% vs 38.6%, p = 0.0132) but not PT or specialist follow-up evaluations. Radiology ordering rates did not correlate with AI-interpreted data review. As neurosurgeons and pediatricians continue to work to limit neonatal radiation exposure and contain healthcare costs, AI-assisted clinical care could be a cheap and easily scalable diagnostic adjunct for reducing reliance on radiography and encouraging adherence to established clinical guidelines. In practice, however, providers appear to default to preexisting diagnostic biases and underweight AI-generated data and interpretations, ultimately negating any potential advantages offered by AI. AI engineers and specialty leadership should prioritize provider education and user interface optimization to improve future adoption of validated AI diagnostic tools.

The management of skeletal-related events (SREs), particularly the prevention of pathological fractures, is crucial for cancer patients. Current clinical assessment of fracture risk is mostly based on medical images, but incorporating sequential images in the assessment remains challenging. This study addressed this issue by leveraging a comprehensive dataset consisting of 260 longitudinal micro-computed tomography (μCT) scans acquired in normal and breast cancer bearing mice. A machine learning (ML) model based on a spatial-temporal neural network was built to forecast bone structures from previous μCT scans, which were found to have an overall similarity coefficient (Dice) of 0.814 with ground truths. Despite the predicted lesion volumes (18.5 ​% ​± ​15.3 ​%) being underestimated by ∼21 ​% than the ground truths' (22.1 ​% ​± ​14.8 ​%), the time course of the lesion growth was better represented in the predicted images than the preceding scans (10.8 ​% ​± ​6.5 ​%). Under virtual biomechanical testing using finite element analysis (FEA), the predicted bone structures recapitulated the loading carrying behaviors of the ground truth structures with a positive correlation (y ​= ​0.863x) and a high coefficient of determination (R² ​= ​0.955). Interestingly, the compliances of the predicted and ground truth structures demonstrated nearly identical linear relationships with the lesion volumes. In summary, we have demonstrated that bone deterioration could be proficiently predicted using machine learning in our preclinical dataset, suggesting the importance of large longitudinal clinical imaging datasets in fracture risk assessment for cancer bone metastasis.

To evaluate the performance of large language models (LLMs) in generating clinically follow-up recommendations for pulmonary nodules by leveraging radiological report findings and management guidelines. This retrospective study included CT follow-up reports of pulmonary nodules documented by senior radiologists from September 1st, 2023, to April 30th, 2024. Sixty reports were collected for prompting engineering additionally, based on few-shot learning and the Chain of Thought methodology. Radiological findings of pulmonary nodules, along with finally prompt, were input into GPT-4o-mini or ERNIE-4.0-Turbo-8K to generate follow-up recommendations. The AI-generated recommendations were evaluated against radiologist-defined guideline-based standards through binary classification, assessing nodule risk classifications, follow-up intervals, and harmfulness. Performance metrics included sensitivity, specificity, positive/negative predictive values, and F1 score. On 1009 reports from 996 patients (median age, 50.0 years, IQR, 39.0-60.0 years; 511 male patients), ERNIE-4.0-Turbo-8K and GPT-4o-mini demonstrated comparable performance in both accuracy of follow-up recommendations (94.6 % vs 92.8 %, P = 0.07) and harmfulness rates (2.9 % vs 3.5 %, P = 0.48). In nodules classification, ERNIE-4.0-Turbo-8K and GPT-4o-mini performed similarly with accuracy rates of 99.8 % vs 99.9 % sensitivity of 96.9 % vs 100.0 %, specificity of 99.9 % vs 99.9 %, positive predictive value of 96.9 % vs 96.9 %, negative predictive value of 100.0 % vs 99.9 %, f1-score of 96.9 % vs 98.4 %, respectively. LLMs show promise in providing guideline-based follow-up recommendations for pulmonary nodules, but require rigorous validation and supervision to mitigate potential clinical risks. This study offers insights into their potential role in automated radiological decision support.

The article discusses advanced three-dimensional evaluation of hallux valgus deformity using weightbearing computed tomography. Conventional two-dimensional radiographs fall short in assessing the complexity of hallux valgus deformities, whereas weightbearing computed tomography provides detailed insights into bone alignment and joint stability in a weightbearing state. Recent studies have highlighted the significance of first ray hypermobility and intrinsic metatarsal rotation in hallux valgus, influencing surgical planning and outcomes. The integration of semiautomatic and artificial intelligence-assisted tools with weightbearing computed tomography is enhancing the precision of deformity assessment, leading to more personalized and effective hallux valgus management.

Bone metastasis is a common and serious complication in lung cancer patients, leading to severe pain, pathological fractures, and reduced quality of life. Early prediction of bone metastasis can enable timely interventions and improve patient outcomes. In this study, we developed a multimodal Swin Transformer-based deep learning model for predicting bone metastasis risk in lung cancer patients by integrating CT imaging and pathological data. A total of 215 patients with confirmed lung cancer diagnoses, including those with and without bone metastasis, were included. The model was designed to process high-resolution CT images and digitized histopathological images, with the features extracted independently by two Swin Transformer networks. These features were then fused using decision-level fusion techniques to improve classification accuracy. The Swin-Dual Fusion Model achieved superior performance compared to single-modality models and conventional architectures such as ResNet50, with an AUC of 0.966 on the test data and 0.967 on the training data. This integrated model demonstrated high accuracy, sensitivity, and specificity, making it a promising tool for clinical application in predicting bone metastasis risk. The study emphasizes the potential of transformer-based models to revolutionize bone oncology through advanced multimodal analysis and early prediction of metastasis, ultimately improving patient care and treatment outcomes.

To develop and evaluate the performance of fully automated model based on deep learning and multiple logistics regression algorithm for image quality assessment (IQA) of carotid computed tomography angiography (CTA) images. This study retrospectively collected 840 carotid CTA images from four tertiary hospitals. Three radiologists independently assessed the image quality using a 3-point Likert scale, based on the degree of noise, vessel enhancement, arterial vessel contrast, vessel edge sharpness, and overall diagnostic acceptability. An automated assessment model was developed using a training dataset consisting of 600 carotid CTA images. The assessment steps included: (i) selection of objective representative slices; (ii) use of 3D Res U-net approach to extract objective indices from the representative slices and (iii) use of single objective index and multiple indices combinedly to develop logistic regression models for IQA. In the internal and external test datasets (n = 240), the performance of models was evaluated using sensitivity, specificity, precision, F-score, accuracy, the area under the receiver operating characteristic curve (AUC), and the IQA results of models was compared with radiologists' consensus. The representative slices were determined based on the same length model. The performance of multi-index model was excellent in internal and external test datasets with AUCs of 0.98 and 0.97. And the consistency between model and radiologists achieved 91.8% (95% CI: 87.0-96.5) and 92.6% (95 % CI: 86.9-98.4) in internal and external test datasets respectively. The fully automated multi-index model showed equivalent performance to the subjective perceptions of radiologists with greater efficiency for IQA.

Lung cancer is one of the leading causes of cancer-related mortality worldwide, with most cases diagnosed at advanced stages where curative treatment options are limited. Low-dose computed tomography (LDCT) for lung cancer screening (LCS) of individuals selected based on age and smoking history has shown a significant reduction in lung cancer-specific mortality. The number needed to screen to prevent one death from lung cancer is lower than that for breast cancer, cervical cancer, and colorectal cancer. Despite the substantial impact on reducing lung cancer-related mortality and proof that LCS with LDCT is effective, uptake of LCS has been low and LCS eligibility criteria remain imperfect. While LCS programs have historically faced patient recruitment challenges, research suggests that there are novel opportunities to both identify and improve screening for at-risk populations. In this review, we discuss the global obstacles to implementing LCS programs and strategies to overcome barriers in resource-limited settings. We explore successful approaches to promote LCS through robust engagement with community partners. Finally, we examine opportunities to enhance LCS in at-risk populations not captured by current eligibility criteria, including never smokers and individuals with a family history of lung cancer, with a focus on early detection through novel artificial intelligence technologies.